Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/NEWRON-PHARMACEUTICALS-S--198001/news/Newron-dammt-Verlust-im-ersten-Semester-2021-leicht-ein-Projekte-im-Plan-36438696/?utm_source=whatsapp&utm_medium=social&utm_campaign=share